Drug General Information
Drug ID
D0Q3UL
Former ID
DPR000090
Drug Name
PD-160170
Synonyms
NCGC00092332-01; BRD-K12079898-001-01-8; 5-nitro-6-(2-propan-2-ylphenyl)sulfonyl-quinolin-8-amine
Drug Type
Small molecular drug
Indication Hypertension; Obesity; Heart disease [ICD9: 278, 390-429; ICD10:E66, I00-I52] Preclinical [536122]
Company
Parke CDavis
Structure
Download
2D MOL

3D MOL

Formula
C18H17N3O4S
Canonical SMILES
CC(C)C1=CC=CC=C1S(=O)(=O)C2=C(C3=C(C(=C2)N)N=CC=C3)[N+]<br />(=O)[O-]
InChI
1S/C18H17N3O4S/c1-11(2)12-6-3-4-8-15(12)26(24,25)16-10-14(19)17-13(7-5-9-20-17)18(16)21(22)23/h3-11H,19H2,1-2H3
InChIKey
YUVNGBZROXQYQH-UHFFFAOYSA-N
CAS Number
CAS 181468-88-2
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Neuropeptide Y receptor type 1 Target Info Antagonist [536122]
KEGG Pathway cAMP signaling pathway
Neuroactive ligand-receptor interaction
NetPath Pathway FSH Signaling Pathway
Reactome Peptide ligand-binding receptors
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Peptide GPCRs
Endothelin Pathways
GPCR ligand binding
GPCR downstream signaling
References
Ref 536122Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60.
Ref 536122Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.